Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

        Date of Report (Date of earliest event reported): April 15, 2002

                          BioMarin Pharmaceutical Inc.
             (Exact name of registrant as specified in its charter)

            Delaware                   000-26727                68-0397820
(State or other jurisdiction of       (Commission             (IRS Employer
 incorporation or organization)       File Number)          Identification No.)

371 Bel Marin Keys Boulevard, Suite 210, Novato, California               94949
(Address of principal executive offices)                              (Zip Code)

Registrant's telephone number, including area code:              (415) 884-6700

                                 Not Applicable
          (Former name or former address, if changed since last report)

Item 5.  Other Events.

                  On April 15, 2002, BioMarin Pharmaceutical Inc. (the
"Registrant"), together with its joint venture partner Genzyme General,
announced the filing of a "Rolling" Biologics License Application with the U.S.
Food and Drug Administration. The Registrant's press release issued on April 15,
2002 is attached hereto as Exhibit 99.1.

Item 7.  Financial Statements, Pro Forma Financial Statements and Exhibits.

         (a)      Financial Statements of Business Acquired.

                  Not Applicable.

         (b)      Pro Forma Financial Information.

                  Not Applicable.

         (c)      Exhibits.

                  Exhibit 99.1      Press Release of the Registrant dated April
                                    15, 2002


         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                        BioMarin Pharmaceutical Inc.,
                                        a Delaware corporation

Date: April 15, 2002                   By: /s/  Fredric D. Price
                                           Fredric D. Price
                                           Chairman and Chief Executive Officer

                                  EXHIBIT INDEX

Exhibit No.                Description

Exhibit 99.1               Press Release of the Registrant dated April 15, 2002